Table 1 Patients’ information in the TCGA.
Characteristic | Low expression of DLEU2 | High expression of DLEU2 | p |
|---|---|---|---|
n | 249 | 250 | |
T stage, n (%) | <0.001 | ||
T2 | 118 (24%) | 71 (14.4%) | |
T3 | 123 (25%) | 169 (34.3%) | |
T4 | 4 (0.8%) | 7 (1.4%) | |
N stage, n (%) | <0.001 | ||
N0 | 178 (41.8%) | 169 (39.7%) | |
N1 | 21 (4.9%) | 58 (13.6%) | |
M stage, n (%) | 0.248 | ||
M0 | 227 (49.6%) | 228 (49.8%) | |
M1 | 0 (0%) | 3 (0.7%) | |
Gleason score, n (%) | <0.001 | ||
6 | 33 (6.6%) | 13 (2.6%) | |
7 | 146 (29.3%) | 101 (20.2%) | |
8 | 23 (4.6%) | 41 (8.2%) | |
9 | 45 (9%) | 93 (18.6%) | |
10 | 2 (0.4%) | 2 (0.4%) | |
Residual tumor, n (%) | 0.270 | ||
R0 | 166 (35.5%) | 149 (31.8%) | |
R1 | 67 (14.3%) | 81 (17.3%) | |
R2 | 3 (0.6%) | 2 (0.4%) | |
PFI event, n (%) | 0.005 | ||
Alive | 215 (43.1%) | 190 (38.1%) | |
Dead | 34 (6.8%) | 60 (12%) | |
Age, n (%) | 0.013 | ||
<=60 | 126 (25.3%) | 98 (19.6%) | |
>60 | 123 (24.6%) | 152 (30.5%) |
